Bcl-xL Gene Expression Correlated with Lower Apoptotic Cell Numbers and Shorter Progression-Free Survival in PCFCL
Open Access
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (7) , 1703-1709
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xLJournal of Medicinal Chemistry, 2007
- Expression of bcl2 family proteins and active caspase 3 in classical Hodgkin's lymphomasHuman Pathology, 2007
- Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphomaBritish Journal of Dermatology, 2001
- Primary cutaneous follicle center cell lymphoma with follicular growth patternBlood, 2000
- Posttranslational Modification of Bcl-2 Facilitates Its Proteasome-Dependent Degradation: Molecular Characterization of the Involved Signaling PathwayMolecular and Cellular Biology, 2000
- Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's LymphomasJournal of Clinical Oncology, 1999
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissuesBlood, 1993
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986